MGCD-265 10mg
10mg
| Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information
Supplier Page
MGCD0103 50mg
50mg
| Purity Not Available
Adooq Bioscience
MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11.
More Information
Supplier Page
MGCD0103 5mg
5mg
| Purity Not Available
Adooq Bioscience
MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11.
More Information
Supplier Page
MGCD0103 25mg
25mg
| Purity Not Available
Adooq Bioscience
MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11.
More Information
Supplier Page
Adooq Bioscience
MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11.
More Information
Supplier Page
MGCD0103 10mg
10mg
| Purity Not Available
Adooq Bioscience
MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11.
More Information
Supplier Page
Adooq Bioscience
Metolazone and the other thiazide diuretics inhibit the function of the sodium-chloride symporter and prevent sodium and chloride, water as well, from leaving the lumen to enter the tubule cell.
More Information
Supplier Page
MGCD-265 5mg
5mg
| Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information
Supplier Page
MGCD-265 50mg
50mg
| Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information
Supplier Page
Adooq Bioscience
Mifepristone, an antioxidant and glucocorticoid receptor antagonist, demonstrates the ability to suppress activation of NF??B, a nuclear transcription factor that affects the expression of various adhesion molecules and several inflammatory genes.
More Information
Supplier Page